XML 36 R26.htm IDEA: XBRL DOCUMENT

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Cash and Cash Equivalents

Cash and cash equivalents consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Cash		$	1,730			$	2,004
Commercial paper			17,328				14,269
Money market funds			8,063				28,241
U.S. government bonds			6,488				5,968
Total cash and cash equivalents		$	33,609			$	50,482

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Insurance proceeds receivable for litigation settlement		$	—			$	28,500
Prepaid assets			2,069				1,903
Other current assets			1,257				1,139
Total prepaid expenses and other current assets		$	3,326			$	31,542

Schedule of Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Preclinical and clinical trial accruals		$	6,151			$	6,327
API and bulk drug product price true-up			13,331				13,071
Litigation settlement			—				28,500
Payroll and related accruals			4,362				4,640
Accrued restructuring charge			2,583				4,572
Professional services			4,626				2,049
Current portion of liability related to sale of future revenues			1,858				460
Other			2,413				2,416
Total accrued and other current liabilities		$	35,324			$	62,035